Patient & Survivor Care
Latest News
AHA statement addresses equity in cardio-oncology care
Statement says developing personalized cardioprotection strategies that integrate biological, genetic, and social determinant markers is one way...
From the Journals
In head and neck cancer, better outcomes seen in patients with overweight
Among 445 patients treated with chemoradiation, those with overweight saw improvements in survival and tumor recurrence, compared with patients...
Latest News
New international guidelines on opioid deprescribing
The recommendations describe best practices for stopping opioid therapy and emphasize slow tapering and individualized deprescribing plans...
From the Journals
Colorectal cancer: Younger patients fare worse
Genetic data also showed increased prevalence of certain mutations in early-onset patients.
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
News from the FDA/CDC
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
From the Journals
Breast cancer family history linked to better BC survival
A family history of breast cancer was associated with a lower risk of breast cancer-specific death, after adjustments, a new study finds.
Conference Coverage
Huge underuse of germline testing for cancer patients
Information from germline genetic testing could affect a patient’s cancer care.
From the Journals
No safe dose of cardiac radiation in children?
“These findings solidify the need to consider cardiac substructure doses in [pediatric] radiation treatment planning and in survivorship care.”
Feature
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...